ADC Therapeutics SA revenue breakdown overview

ADC Therapeutics SA revenue for the last year amounted to 70.84 M USD, the most of which — 70.84 M USD — came from its highest performing source at the moment, Antibody Drug Conjugate Cancer Therapies, the year earlier bringing 69.56 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought ADC Therapeutics SA 69.28 M USD, and the year before that — 69.06 M USD.